Arno Motulsky
http://dbpedia.org/resource/Arno_Motulsky an entity of type: Thing
Arno Gunther Motulsky (* 5. Juli 1923 in Fischhausen, Ostpreußen; † 17. Januar 2018 in Seattle) war ein deutsch-amerikanischer Arzt, Genetiker und Mitbegründer der Pharmakogenetik. Von 1959 bis zu seiner Pensionierung war er Direktor der Klinik für Genetik an der University of Washington in Seattle. In einem Nachruf in der New York Times wurde der Direktor der US-amerikanischen National Institutes of Health, Francis Collins, mit den Worten zitiert: „Der Zusammenhang zwischen Vererbung und dem Ansprechen auf Arzneimittel-Therapie, darüber hat niemand nachgedacht bis er vor 60 Jahren damit begonnen hat.“
rdf:langString
Arno Gunther Motulsky (5 July 1923 – 17 January 2018) was a professor of medical genetics and genome sciences at the University of Washington. Through his research, writing and mentoring, he helped create and define the field of medical genetics. He is also known as the "father of pharmacogenomics" (the study of how drug action and metabolism differ among people due to genetic variability) based on his report in 1957 of negative drug responses in some patients depending upon their genetics at critical enzymes.[2]
rdf:langString
rdf:langString
Arno Motulsky
rdf:langString
Arno Motulsky
rdf:langString
Arno Motulsky
rdf:langString
Arno Motulsky
rdf:langString
Seattle, Washington, U.S.
xsd:date
2018-01-17
xsd:date
1923-07-05
xsd:integer
47967088
xsd:integer
1105313321
rdf:langString
GfH - Medal of Honor
rdf:langString
McKusick Leadership Award
xsd:date
1923-07-05
rdf:langString
German
rdf:langString
USA
xsd:date
2018-01-17
rdf:langString
Human genetics, Phamacogenetics
rdf:langString
American
xsd:date
2009-09-17
rdf:langString
Arno Gunther Motulsky (5 July 1923 – 17 January 2018) was a professor of medical genetics and genome sciences at the University of Washington. Through his research, writing and mentoring, he helped create and define the field of medical genetics. He is also known as the "father of pharmacogenomics" (the study of how drug action and metabolism differ among people due to genetic variability) based on his report in 1957 of negative drug responses in some patients depending upon their genetics at critical enzymes.[2] Dr. Motulsky joined the faculty at the University of Washington School of Medicine in 1953. In 1957 he founded The Division of Medical Genetics at the University of Washington in 1957. Over his career Dr. Motulsky made many significant contributions to research, patient care and education in human genetics. He was noted for his work on blood diseases, the heritability of lipid disorders, the role of genetic variation in disease, and genetic reasons why people differ in their responses to medications and environmental substances.
rdf:langString
Arno Gunther Motulsky (* 5. Juli 1923 in Fischhausen, Ostpreußen; † 17. Januar 2018 in Seattle) war ein deutsch-amerikanischer Arzt, Genetiker und Mitbegründer der Pharmakogenetik. Von 1959 bis zu seiner Pensionierung war er Direktor der Klinik für Genetik an der University of Washington in Seattle. In einem Nachruf in der New York Times wurde der Direktor der US-amerikanischen National Institutes of Health, Francis Collins, mit den Worten zitiert: „Der Zusammenhang zwischen Vererbung und dem Ansprechen auf Arzneimittel-Therapie, darüber hat niemand nachgedacht bis er vor 60 Jahren damit begonnen hat.“
rdf:langString
Charles J. Epstein
rdf:langString
David E. Comings
rdf:langString
Gil Omenn
rdf:langString
Judith Hall
xsd:nonNegativeInteger
17106
